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Abstract
Background: Mobile group II introns insert site-specifically into DNA target sites by a mechanism termed retrohoming in
which the excised intron RNA reverse splices into a DNA strand and is reverse transcribed by the intron-encoded protein.
Retrohoming is mediated by a ribonucleoprotein particle that contains the intron-encoded protein and excised intron RNA,
with target specificity determined largely by base pairing of the intron RNA to the DNA target sequence. This feature
enabled the development of mobile group II introns into bacterial gene targeting vectors (‘‘targetrons’’) with programmable
target specificity. Thus far, however, efficient group II intron-based gene targeting reactions have not been demonstrated in
eukaryotes.
Methodology/Principal Findings: By using a plasmid-based Xenopus laevis oocyte microinjection assay, we show that
group II intron RNPs can integrate efficiently into target DNAs in a eukaryotic nucleus, but the reaction is limited by low
Mg
2+ concentrations. By supplying additional Mg
2+, site-specific integration occurs in up to 38% of plasmid target sites. The
integration products isolated from X. laevis nuclei are sensitive to restriction enzymes specific for double-stranded DNA,
indicating second-strand synthesis via host enzymes. We also show that group II intron RNPs containing either lariat or
linear intron RNA can introduce a double-strand break into a plasmid target site, thereby stimulating homologous
recombination with a co-transformed DNA fragment at frequencies up to 4.8% of target sites. Chromatinization of the
target DNA inhibits both types of targeting reactions, presumably by impeding RNP access. However, by using similar RNP
microinjection methods, we show efficient Mg
2+-dependent group II intron integration into plasmid target sites in zebrafish
(Danio rerio) embryos and into plasmid and chromosomal target sites in Drosophila melanogster embryos, indicating that
DNA replication can mitigate effects of chromatinization.
Conclusions/Significance: Our results provide an experimental foundation for the development of group II intron-based
gene targeting methods for higher organisms.
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Introduction
Mobile group II introns employ a remarkable site-specific DNA
integration mechanism, termed retrohoming, in which the excised
intron RNA inserts directly into a DNA target site and is then
reverse transcribed by the intron-encoded protein (IEP) [1,2]. This
process is mediated by a ribonucleoprotein particle (RNP), which
is formed during RNA splicing and contains the IEP and excised
intron lariat RNA. RNPs initiate DNA integration by recognizing
DNA target sites, with most of the target sequence recognized by
base pairing of the intron RNA and only a small number of bases
recognized by the IEP [3–7]. This feature together with their high
insertion frequencies and specificity enabled the development of
mobile group II introns into novel bacterial gene targeting vectors
(‘‘targetrons’’), which can be programmed to insert efficiently into
desired DNA targets simply by modifying the intron RNA [8].
Targetrons have been used to obtain gene knock-outs and knock-
ins in diverse Gram-negative and Gram-positive bacteria,
including medically and commercially important species in which
gene targeting by other methods had previously been difficult or
impossible [9–15]. Thus far, however, it has not been shown that
targetrons can function efficiently in eukaryotic cells.
The Lactococcus lactis Ll.LtrB intron has been used as a model
system both to study group II intron mobility and to develop gene
targeting applications [1]. Ll.LtrB encodes a protein, denoted
LtrA, with four conserved domains: RT, which corresponds to the
fingers and palm regions of retroviral RTs; X, which corresponds
at least in part to the RT thumb; DNA-binding (D); and DNA
endonuclease (En). The RT and X domains bind specifically to the
intron RNA to stabilize the catalytically active RNA structure for
RNA splicing and reverse splicing, while the D and En domains
interact with DNA target sites during intron mobility. For DNA
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site positions -12 to +2 (numbered from the intron-insertion site),
while the IEP recognizes a small number of nucleotide residues in
the flanking 59- and 39-exon regions. The IEP interactions in the
distal 59-exon lead to local DNA melting, enabling the intron RNA
to base pair to a target sequence in one DNA strand, while the IEP
interactions with the 39 exon are required for En-domain cleavage
between positions +9 and +10 of the opposite strand. The 39 DNA
end generated at the cleavage site is then used by the IEP as a
primer for reverse transcription of the inserted intron RNA,
resulting in an intron cDNA that is integrated by host enzymes
[16,17]. Unlike retroviral RTs, the LtrA protein lacks an RNase H
domain for degradation of the intron RNA template strand and
has very low processive DNA-dependent DNA polymerase activity
for second-strand synthesis, necessitating the use of host enzymes
for these functions [17].
For gene targeting in bacteria, the Ll.LtrB intron is introduced via
a donor plasmid, which expresses an Ll.LtrB-DORF intron with
flanking exons, followed by the LtrA protein from a position just
downstream of the 39 exon [4,8]. The intron is targeted to desired
sites with the aid of a computer algorithm, which scans the target
sequence for the best matches to the positions recognized by the IEP
and then designs PCR primers for modifying the intron to base pair
optimally to those sites [7]. The positions recognized by the IEP are
sufficiently few and flexible that the algorithm generally identifies
multiple rank-ordered target sites in any gene. Further, the intron
can be targeted to insert in different orientations by targeting one or
the other DNA strand, making it possible to obtain either
unconditional or conditional disruptions, depending on whether
the intron is in the correct orientation to be spliced from precursor
RNA by providing the LtrA protein [8,9,11]. Selectable markers can
be incorporated into the intron, but because integration frequencies
are usually high, the desired integrants are often identified simply by
colony PCR screening without selection [7].
It would be highly desirable to develop analogous group II intron-
based gene targeting methods for higher organisms. With the
exception of mouse embryonic stem cells and a few other cell types,
mammalian cells and those of other higher eukaryotes lack efficient
homologous recombination systems for gene targeting [18,19].
Although RNAi has been a major advance in genetic manipulation
in higher organisms, it yields ‘‘knock downs’’ rather than ‘‘knock
outs’’, requires continuous expression or repeated introduction, has
off-target effects, and does not permit the introduction of new genes
[20–22]. Currently available gene therapy vectors, either do not
integratestably(adenovirus)orinsertatmultiple,semi-randomDNA
sites with possible deleterious effects (retroviruses, rep-deficient
adeno-associated virus; AAV) [23–27].
To overcome such deficiencies, alternative gene targeting
methods are being developed, employing different means to
increase the frequency of homologous recombination. One of the
best developed of such methods for human cells, homologous
recombination with recombinant AAV, generally yields 0.1–15%
of integrations at the desired target site [28,29]. Other methods
with potentially higher specificity involve the use of site-specific
DNA endonucleases, such as meganucleases or artificial Zn-finger
nucleases, to make a targeted double-strand break that promotes
homologous recombination [30–33]. Recently, efficient gene
targeting in mammalian cells has been achieved by using Zn-
finger nucleases in this way to stimulate homologous recombina-
tion with a co-transformed donor DNA [34–36]. This method has
been reported to give recombination frequencies up to 29% in
mammalian cells and is efficient enough to target both alleles in
diploids. Zn-finger nucleases have also been used to obtain gene
disruptions in mammalian cells by incorrect nonhomologous end-
joining [37] and are being applied for gene targeting in plants and
eukaryotic model organisms [38–42]. Ultimately, the utility of this
and other methods will depend on the ease of designing and
optimizing protein endonucleases to recognize different DNA
target sequences, their specificity and toxicity, and their cost and
availability compared to other gene targeting methods.
Although still undeveloped for use in eukaryotes, mobile group II
introns can potentially be employed in the same way as Zn-finger
nucleases and meganucleases to introduce a targeted double-strand
break that stimulates homologous recombination or yields mutations
by inaccurate non-homologous end-joining [8]. In the case of group
II introns, the double-strand break results from the initial reverse
splicing and second-strand cleavage reactions. Reverse splicing
occurs in two steps, the first of which is attachment of intron lariat
RNA to the 59 end of the 39 exon leaving a strand break, while
second-strand cleavage is a conventional DNA endonuclease
reaction catalyzed by the IEP [1]. Compared to protein endonu-
cleases, group II introns offer the potential advantage that the
double-strand break can be targeted to different locations simply by
modifying the base pairing sequences in the intron RNA, thereby
obviating the need for protein engineering to change target
specificity [8]. Mobile group II introns, like retroviruses to which
they are related, can also be used as integrating vectors, enabling the
insertion of cargo genes at desired sites, with the advantage of high,
controllable DNA target specificity [5,9,43].
Previously, we retargeted the Ll.LtrB group II intron to insert in
the HIV-1 provirus and the human gene encoding the HIV-1 co-
receptor CCR5 and showed that the retargeted introns insert into
their target sites with high frequency and specificity in Escherichia
coli plasmid assays [4]. We also used E. coli assays to show that
group II introns could be used for genetic repair, either by
inserting a functional copy of the gene into a defective gene, or by
inserting functional exons preceded by a splice acceptor site to
circumvent defective downstream exons [43]. Such retargeted
group II intron RNPs retained activity in human cell assays in
which plasmid-borne target sites and group II intron RNPs were
introduced separately by liposome-mediated transfection [4]. In
these initial experiments, however, group II intron integration into
plasmid target sites in human cells was much less efficient than in
bacteria, requiring nested PCR for detection.
There was reason to believe that group II introns might be
particularly sensitive to low Mg
2+ concentrations in eukaryotic cells.
In the yeast Saccharomyces cerevisiae, mutations in mitochondrial Mg
2+-
transport proteins, which result in decreased intramitochondrial
Mg
2+ concentrations, strongly inhibited the splicing of all four
mtDNA group II introns, while having much less effect on the
splicing of group I introns [44,45]. Standard in vitro reaction
conditions for the Ll.LtrB intron use 5 mM Mg
2+ for IEP-promoted
RNA splicing and 10 mM Mg
2+ for reverse splicing of RNPs into
DNA target sites [46]. Thus, it is possible that group II intron RNPs
are unable to function optimally in eukaryotic nuclei where the free
Mg
2+ concentration is estimated to be 1–2 mM [47].
Here, we used a Xenopus laevis oocyte microinjection assay to show
that group II intron RNPs can insert efficiently into a plasmid target
site in eukaryotic nuclei, but require the injection of additional
MgCl2. In such assays under optimal conditions, group II intron
RNP integration frequencies were as high as 38% and targeting
frequencies by double-strand break- stimulated homologous recom-
bination were as high as 4.8%. Analogous RNP microinjection
assays show relatively efficient Mg
2+-dependent group II intron
integration into plasmid target sites in D. melanogaster and zebrafish
(Danio rerio) embryos and into chromosomal target sites in D.
melanogaster embryos. Our results demonstrate the potential for using
group II introns for gene targeting reactions in higher organisms.
Group II Intron Targeting
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Site-specific group II intron integration into plasmid
target sites in X. laevis oocyte nuclei
To assay group II intron targeting reactions in X. laevis oocyte
nuclei, we used a plasmid assay patterned after one developed to
assay group II intron mobility in E. coli (Fig. 1A) [4,8]. In the E. coli
assay, an Ll.LtrB intron with a phage T7 promoter inserted near
its 39 end integrates into a target site (the ligated E1-E2 sequence
of the ltrB gene) cloned upstream of a promoterless tet
R gene in an
Amp
R target plasmid. Insertion of the intron containing the T7
promoter into the target site activates the tet
R gene, enabling
intron-integration efficiencies to be measured by the ratio of
(Tet
R+Amp
R)/Amp
R colonies. For gene targeting applications, we
generally use a streamlined 0.9-kb derivative of the Ll.LtrB intron
from which ORF sequences encoding the IEP have been deleted.
This Ll.LtrB-DORF intron has much higher integration efficiency
and nuclease-resistance than does the full-length intron [4].
The protocol used for the assays in X. laevis oocyte nuclei is
shown in Figure 1B. The target plasmid (pBRR3-1trB) containing
the ltrB target site was injected first, followed within 1 min by
Ll.LtrB RNPs reconstituted with self-spliced Ll.LtrB-DORF lariat
RNA and purified recombinant LtrA protein (see Materials and
Methods). In all the X. laevis experiments, the DNA target plasmid
and RNPs were injected using different needles to avoid prior
mixing, and 10 or more oocytes were injected for each
experimental condition. After incubation for times specified for
individual experiments, the oocytes for each condition were
pooled, and nucleic acids were extracted and electroporated into
E. coli HMS174(DE3), which expresses phage T7 RNA polymer-
ase. The cells were then plated on LB medium containing
ampicillin with or without tetracycline to determine the mobility
efficiency as described above.
As shown in Table 1, when the target plasmid DNA and intron
RNPswere injectedwithoutfurther additions,no Tet
R colonieswere
obtained. In light of the previous studies indicating that group II
introns are particularly sensitive to low Mg
2+ concentrations (see
Introduction), we repeated the experiment, now injecting the target
plasmid in a solution containing 500 mM MgCl2.U n d e rt h e s e
conditions, the RNP integration efficiency increased dramatically to
27% in this experiment. We confirmed that the intron had
integrated precisely at the expected target site by sequencing both
the 59-a n d3 9-integration junctions in plasmids isolated from seven
independent Tet
R colonies (not shown), and controls showed no
Tet
R colonies after heating the RNPs to 95uC for 3 min or using
RNPs reconstituted with a mutant LtrA protein that lacks RT
activity (RT
2). The integration efficiency was proportional to the
amount of RNPs injected (not shown) and with different batches of
RNPs ranged up to 38% of plasmid target sites (with injection of 20
nl of 2.5 mg/ml RNPs). Finally, efficient integration was obtained
only when both the RNP and target plasmid were injected into the
nucleus and not when they were injected into the cytoplasm
(Table 1). Together, these experiments show that under appropriate
conditions, the site-specific group II intron-integration reaction can
occur efficiently in eukaryotic nuclei.
Effect of Mg
2+, dNTPs, and temperature on group II
intron integration in X. laevis oocyte nuclei
To determine the optimal injected Mg
2+ concentration for group
II intron integration, we measured the group II intron-integration
efficiency at different MgCl2 concentrations injected in a volume of
18 nl with plasmid DNA. Figure 2A shows that the highest
Figure 1. Group II intron-integration assay in X. laevis oocyte
nuclei. (A) Plasmid assay. Microinjected group II intron RNPs containing
a 0.9-kb Ll.LtrB-DORF intron RNA with a T7 promoter in DIV and the
group II intron RT integrate into a target site (ligated ltrB exon 1 and 2
sequences; E1 and E2) cloned upstream of a promoterless tet
R gene in
an Amp
R target plasmid (pBRR3-ltrB), thereby activating the tet
R gene.
T1 and T2 are E. coli rrnB transcription terminators, and Tw is a phage T7
transcription terminator. (B) Protocol. Target plasmids and RNPs were
injected into oocyte nuclei using different needles. After incubating the
oocytes for different times, nucleic acids were isolated and electropo-
rated into E. coli HMS174(DE3). The integration efficiency was calculated
as the ratio of (Tet
R+Amp
R)/Amp
R colonies.
doi:10.1371/journal.pone.0003121.g001
Table 1. Site-specific integration of a group II intron into a
plasmid target site in X. laevis oocyte nuclei.
Condition Amp
R+Tet
R Amp
R Integration (%)
RNP+TP 0 9.4610
4 ,0.001
RNP+TP+MgCl2 4.8610
3 1.8610
4 27
Heated RNP+TP+MgCl2 05 . 5 610
4 ,0.002
RNP/RT
2+TP+MgCl2 01 . 7 610
4 ,0.006
RNPs+TP+MgOAc 6.2610
2 1.5610
4 4.1
RNPs+TP+MgSO4 5.1610
2 1.8610
4 2.8
RNPs+TP+MnCl2 03 . 5 610
3 ,0.03
RNPs+TP+CaCl2 02 . 5 610
3 ,0.04
RNPs+TP+MgCl2 (cyto) 23 4.6610
4 0.05
Target plasmid pBRR3-ltrB (TP; 4.6 ng, 18 nl) and Ll.LtrB intron RNPs (32 ng, 16
nl) were injected separately into X. laevis oocyte nuclei. After incubating for 2 h
at 25uC, nucleic acids were extracted from 10 pooled oocytes for each
condition, electroporated into E. coli HMS174(DE3), and assayed for site-specific
group II intron integration into the plasmid target site by determining the ratio
of (Tet
R+Amp
R)/Amp
R colonies, as described in Figure 1 and Materials and
Methods. In a control (row 3), RNPs were heated to 95uC for 3 min before
injection. MgCl2, Mg acetate, MgSO4, MnCl2, and CaCl2 were injected at a
concentration of 500 mM with the target plasmid. In all assays, 17 mM dNTPs
was included with the target plasmid, except those for MnCl2 and CaCl2 due to
the formation of precipitates. In one assay (bottom row), the RNPs and target
plasmid plus MgCl2 and dNTPs were injected into the cytoplasm instead of the
nucleus. The Table shows the integration efficiency determined by the average
number of (Tet
R+Amp
R) and Amp
R colonies based on counting three plates at
appropriate dilutions. Assays for all conditions were repeated at least once with
similar results.
doi:10.1371/journal.pone.0003121.t001
Group II Intron Targeting
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2+
concentration was 500 mM. Assuming that the oocyte has a volume
of 1 ml and that all of the injected Mg
2+ remains free, this injection
would raise the intracellular Mg
2+ concentration by ,9 mM, close
to the Mg
2+ optimum for the DNA integration reaction [46]. MnCl2
or CaCl2 could not substitute for MgCl2, and Mg acetate or MgSO4
gave significantly lower intron-integration frequencies than did
MgCl2 (Table 1). The order of injection of DNA and RNPsmade no
difference,andtheMg
2+couldbe injected separatelyfromthe DNA.
However, high Mg
2+ concentrations could not be injected with the
RNPs because it caused them to aggregate, making double-injection
necessary (not shown).
Studies with bovine capillary endothelial cells showed that the
addition of 65 mM MgCl2 to the culture medium results in
chromosome unfolding [48]. While this may also occur in X. laevis
oocyte nuclei and could facilitate group II intron integration, we
found that addition of 10–500 mM MgCl2 to the X. laevis oocyte
incubation medium resulted in little or no increase in the group II
intron-integration efficiency (the maximum was 4610
24 % with
65 mM MgCl2).
In early experiments, there was considerable variation in the
intron-integration efficiency between different batches of oocytes
(insertion frequencies 0.002–7%). Later, we found that this problem
could be mitigated by addition of 17–20 mM each of dATP, dCTP,
dGTP, anddTTP(‘‘dNTPs’’) to the DNA/MgCl2 injection mixture,
which increased group II intron-integration frequencies in subop-
timal oocytes to .3% (not shown). Higher dNTP concentration did
not furtherincreasetheintegration frequencies.Inlaterexperiments,
17 mM dNTPs were added routinely.
In experiments done at optimal Mg
2+ and dNTP concentrations,
the highest integration efficiencies were obtained at temperatures of
25–30uC (Fig. 2B). Integration was barely detectable at 16uCa n d
was inhibited somewhat at 37uC, possibly reflecting the deleterious
effect of high temperature on the oocyte. Temperatures$30uCa r e
known to activate the heat-shock response and block transcription in
X. laevis oocytes [49]. Based on the above experiments, 500 mM
Figure 2. Determination of optimal conditions for site-specific integration of group II intron RNPs into a plasmid target site in X.
laevis oocyte nuclei. (A) Mg
2+-concentration dependence. Target plasmid DNA (10 ng) with 0 to 2,000 mM MgCl2 and 17 mM dNTPs was injected
into X. laevis oocyte nuclei followed by Ll.LtrB lariat RNPs (50 ng). The oocytes were incubated for 2 h at 25uC. (B) Temperature dependence. Target
plasmid DNA (9 ng) with 500 mM MgCl2 and 17 mM dNTPs was injected into X. laevis oocyte nuclei followed by Ll.LtrB lariat RNPs (50 ng). The
oocytes were incubated for 2 h at different temperatures. (C and D) Time courses at 25uCo r3 0 uC, respectively. Target plasmid DNA (4.5 ng) with
500 mM MgCl2 and 17 mM dNTPs was injected into X. laevis oocyte nuclei, followed by Ll.LtrB lariat RNPs (36 ng). The oocytes were incubated for the
indicated times and then quick frozen on dry ice. Nucleic acids isolated from the 25uC-incubated oocytes were untreated or digested with KpnI or
MluI (10 units; New England Biolabs) for 1 h at 37uC and then extracted twice with phenol-CIA and ethanol precipitated prior to electroporation into
E. coli. In (A)–(D), injection volumes were 18 nl. Integration efficiencies (%) were determined by electroporating nucleic acids extracted from oocytes
into E. coli HMS174(DE3), followed by plating to determine ratios of (Tet
R+Amp
R)/Amp
R colonies, as described in Figure 1 and Materials and Methods.
Each experiment was repeated at least once with essentially the same results.
doi:10.1371/journal.pone.0003121.g002
Group II Intron Targeting
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routinely in the experiments below.
Time-course of intron integration and nuclease
sensitivity of retrohoming products
In time-course experiments at 25 or 30uC, retrohoming
products appeared after 10 min and increased for at least
120 min, reaching maximum values of 8–10% in those experi-
ments (Fig. 2C and 2D). No mobility products were detected when
the oocytes were frozen immediately after injection. In some
experiments, integration frequencies reached a plateau at
120 min, while in other experiments they continued to increase
overnight (Fig. S1).
To determine whether second-strand synthesis could occur in X.
laevis oocyte nuclei, a portion of the nucleic acids isolated at
different time points was digested with the restriction enzymes
KpnI or MluI, prior to transformation into E. coli for the Tet
R
colony assay (Fig. 2C). KpnI and MluI have single cleavage sites
within the intron and cleave double-stranded but not single-
stranded DNA or RNA/DNA hybrids (verified by control
experiments with DNA oligonucleotide substrates under the
conditions used; Fig. S2). At the earliest time point (10 min),
KpnI or MluI digestion had no significant effect on the recovery of
Tet
R colonies, while at longer time points KpnI or MluI digestion
virtually abolished the recovery of Tet
R colonies. By contrast,
RNase H, which cleaves RNA in RNA/DNA heteroduplexes, or
RNase A, which under low-salt conditions (50 mM NaCl) cleaves
either single-stranded RNA or RNA in RNA/DNA heterodu-
plexes, had little if any effect (RNase A gave a,38% decrease at
any time point in the experiment of Fig. 2C (not shown), and
neither RNase A nor RNase H had a significant effect within
experimental error in the experiment of Fig. S1). The specificities
of RNase H and RNase A under the conditions used were also
verified by control experiments with synthetic oligonucleotide
substrates (Fig. S2). The finding that the intron-integration
products isolated from X. laevis oocyte nuclei at longer time points
are almost completely sensitive to restriction enzymes that cut
within the intron but insensitive to RNases H or A indicates that
the integrated intron had been largely converted to double-
stranded DNA, presumably with the help of host enzymes for
second-strand DNA synthesis (see Introduction).
Group II intron-stimulated homologous recombination
We showed previously that the Ll.LtrB group II intron could be
used in E. coli to generate a targeted double-strand break that
stimulates gene targeting by homologous recombination with a co-
transformed DNA fragment by at least one to two orders of
magnitude [8]. To test whether the Ll.LtrB intron could be used to
introduce a recombinogenic double-strand break in X. laevis oocyte
nuclei, we developed the assay shown in Figure 3. In this assay, the
closed-circular target plasmid (pBRR3-ltrB), containing the Ll.LtrB
intron-insertion site (IS), was co-injected with a 5.4-kb linear donor
DNA and 500 mM MgCl2. The donor DNA consists of ,4-kb of
unrelated DNA sequence (3,967-bp phage l DNA NcoI fragment)
with a T7 promoter flanked by 705- and 718-bp homology arms
corresponding to sequences on either side of the intron-insertion site
in the recipient plasmid. After injecting the DNAs, we injected
Ll.LtrB-DORF lariat RNPs, without an internal T7 promoter, into
the same oocyte nuclei. Introduction of a double-strand break at the
Ll.LtrB target site by the intron RNPs is expected to stimulate
homologous recombination, resulting in insertion of donor DNA
containing the T7 promoter upstream of the promoterless tet
R gene.
After incubating the oocytes, nucleic acids were isolated and
electroporated into E. coli, and the recombination (‘‘targeting’’)
efficiency was measured by the ratio of (Tet
R+Amp
R)/Amp
R
colonies, as in the group II intron-integration assays.
As summarized in Table 2, the targeting efficiency in the presence
of RNPs was 2.2% compared to 0.01% in the absence of RNPs, a
greater than 200-fold stimulation (In other experiments, there was no
detectable background of recombination in the absence of RNPs).
The expected recombinant plasmid product obtained in the
presence of RNPs was confirmed by sequencing the 39-integration
junction in plasmid DNAs from eight Tet
R colonies (not shown). In
other experiments under the same conditions, targeting efficiencies
Figure 3. Assay of group II intron-RNP stimulated homologous
recombination in X. laevis oocyte nuclei. A target plasmid (pBRR3-
ltrB) containing the Ll.LtrB intron-insertion site (IS; ligated ltrB exon 1
and 2 sequences; E1 and E2) was co-injected into X. laevis oocyte nuclei
with a 5.4-kb linear donor DNA, consisting of a 4-kb phage l sequence
with an inserted T7 promoter, flanked by 705- and 718-bp sequences
homologous to those flanking the Ll.LtrB-insertion site in the target
plasmid. Ll.LtrB RNPs containing the 0.9-kb Ll.LtrB-DORF intron and the
group II intron RT were then injected into the same oocyte nuclei. A
double-strand break resulting from intron RNA reverse splicing and
second-strand cleavage at the Ll.LtrB target site stimulates homologous
recombination, resulting in the insertion of the donor DNA containing
the T7 promoter, thereby activating the tet
R gene. Nucleic acids were
isolated and electroporated into E. coli HMS174(DE3), and the targeting
efficiency was calculated as the ratio of (Tet
R+Amp
R)/Amp
R colonies.
doi:10.1371/journal.pone.0003121.g003
Table 2. Group II intron-stimulated homologous
recombination in X. laevis oocyte nuclei.
Condition Amp
R+Tet
R Amp
R Targeting (%)
WT 2.2610
2 9.9610
3 2.2
-RNP 1.6 1.6610
4 0.01
Heated RNP 0 1.6610
4 ,0.006
-Donor DNA 0 4.2610
3 ,0.02
-MgCl2 01 . 5 610
4 ,0.007
Precut TP 8.6610
2 1.3610
3 66
Circular Donor DNA 0 2.1610
4 ,0.005
Target plasmid pBRR3-ltrB (TP; 4.1 ng) and linear donor DNA (17 ng) were
injected together into X. laevis oocyte nuclei in 17 nl of a solution containing
500 mM MgCl2, followed within 1 min by injection of Ll.LtrB RNPs (34 ng, 17 nl)
reconstituted with Ll.LtrB lariat RNA without a T7 promoter in DIV. After a 2-h
incubation at 25uC, nucleic acids were extracted from 10 pooled oocytes for
each condition and electroporated into E. coli HMS174(DE3). In one sample, the
target plasmid was precut with BtrI 27-bp upstream of the intron target site and
injected without group II intron RNPs. Targeting frequencies were determined
by the ratio of (Tet
R+Amp
R)/Amp
R colonies, as in intron-integration assays (Fig. 1
and Materials and Methods). Experiments for each condition except precut
target plasmid DNA were repeated at least once with similar results.
doi:10.1371/journal.pone.0003121.t002
Group II Intron Targeting
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target plasmid that had been pre-cut with a restriction enzyme and
tested in the same assay without RNPs gave a recombination
frequency of 66% (Table 2). As expected, no Tet
R colonies were
detected if the RNPs had been heat-inactivated at 95uCf o r3m i n ,
nor if eitherthe donorDNA orthetargetplasmid wereomitted from
the assay (Table 2). Further, donor DNA that had not been
linearized did not give detectable recombination (,0.005%), as
expected for the single-strand annealing recombination pathway,
which predominates in X. laevis oocyte nuclei and requires free ends
on both the donor and recipient [50,51]. As for site-specific group II
intron integration, the group II intron-stimulated homologous
recombination reaction was strongly dependent upon the injection
of additional Mg
2+, with recombination in the absence of injected
Mg
2+ falling to undetectable levels (,0.007%; Table 2). In the
presence of Mg
2+, addition of dNTPs did not significantly increase
the targeting efficiency (not shown). Together, these findings show
that Ll.LtrB RNPs can be used in X. laevis oocyte nuclei to introduce
a targeted double-strand break that stimulates gene targeting by
homologous recombination.
Biochemical activities of group II intron RNPs containing
linear instead of lariat intron RNA
We wished to test whether RNPs reconstituted with linear
intron RNA could be used to introduce the recombinogenic
double-strand break at the target site. The rationale was that while
linear intron RNA cannot undergo both transesterification
reactions required for full reverse splicing, it is expected to be
fully competent to carry out the first transesterification, i.e., ligation
of the 39 end of the intron RNA to the 59 end of the 39 exon,
leaving a DNA-strand break [52]. The use of linear intron RNA,
which can be obtained directly by in vitro transcription without the
self-splicing step required to generate lariat RNA, would facilitate
the preparation of RNPs.
First, we carried out biochemical assays to confirm that Ll.LtrB
RNPs reconstituted with linear intron RNA could carry out the
expected reactions. Figure 4A shows an experiment in which
linear and lariat intron RNPs were incubated in vitro with an
internally labeled double-stranded DNA oligonucleotide substrate
containing the Ll.LtrB-insertion site, and the products were
analyzed by electrophoresis in a denaturing polyacrylamide gel. As
found previously [53], the RNPs containing lariat RNA gave
products resulting from both full and partial reverse splicing of the
intron RNA into the top strand, along with two closely spaced
fragments resulting from IEP cleavage of the bottom strand
(Fig. 4A, lane 3). By contrast, the RNPs containing linear intron
RNA did not yield the same fully reverse-spliced product and
intermediate containing attached lariat RNA as did lariat RNPs,
but did cleave the top strand by partial reverse splicing, resulting in
a small band corresponding to the 59 exon (59 top) and a high-
molecular weight product containing linear intron RNA attached
to the 59 end of the 39 exon (Fig. 4A, lane 2). The RNPs containing
linear intron RNA also carried out IEP cleavage of the bottom
strand, producing the same two closely spaced fragments as lariat
RNPs (59 and 39 bottom; Fig. 4A, lane 2).
Figure 4B and C show additional reactions in which RNPs
containing linear or lariat intron RNA were incubated with DNA
substrates labeled at the 59 end of the top or bottom strand,
respectively, in the presence of dNTPs to support target-DNA-
primed reverse transcription. The reactions with the 59-top-strand
labeled substrate confirm that RNPs reconstituted with linear
intron RNA cleave the top strand and show that the reaction can
occur as efficiently as cleavage by lariat RNA (Fig. 4B, lanes 1 and
2). The reactions with 59-labeled bottom strand show that the
cleaved bottom strand can be used as a primer for reverse
transcription of the linear intron, yielding higher molecular weight
product with different lengths of attached cDNA (Fig. 4C, lanes 1
and 2). The gels also show that cDNA synthesis increases the
proportion of fully reverse-spliced product obtained with lariat
RNPs, presumably by pulling the unfavorable equilibrium for full
reverse splicing toward completion (Fig. 4B, lane 2) [54], and that
lariat or linear intron RNPs reconstituted with mutant LtrA
protein that lacks RT activity can still carry out reverse splicing
and top- and bottom-strand cleavage even though they cannot
synthesize cDNA (Fig. 4A, lanes 4 and 5, and Fig. 4B and C, lanes
3). Most importantly for gene targeting, the biochemical
experiments show that group II intron RNPs reconstituted with
linear intron RNA can introduce a double-strand break resulting
from top and bottom strand cleavage at the DNA target site.
Group II intron-stimulated homologous recombination
using RNPs reconstituted with linear intron RNA
Having demonstrated the appropriate reactions in vitro, we next
compared the ability of RNPs reconstituted with linear or lariat
intron RNA to promote gene targeting by group II intron-
stimulated homologous recombination in X. laevis oocyte nuclei.
Gene targeting was again assayed by recombination of a donor
DNA containing a T7 promoter into the recipient plasmid target
site to activate the downstream tet
R gene. As shown in Table 3,
with all RNP preparations diluted to 1.9 mg/ml based on O.D.260
measurements, the RNPs containing linear intron RNA stimulated
gene targeting by recombination at an efficiency of about one third
that of RNPs reconstituted with lariat RNA (0.9 and 0.26%,
respectively). This difference in efficiency is within the range of
variation for different RNP preparations, but could also reflect
that the linear intron RNA transcribed in vitro has heterogeneous
39 ends due to imprecise transcription termination by T3 RNA
polymerase (see Materials and Methods).
We also tested if lariat and linear intron RNPs containing RT-
deficient LtrA could be used to introduce the recombinogenic
double-strand break. We thought that such RNPs might give
higher targeting efficiencies because they can stimulate homolo-
gous recombination by cleaving the target site without being able
to synthesize a cDNA into the site. Surprisingly, we found that the
RT-deficient lariat and linear RNPs have greatly decreased
targeting efficiencies (0.03 and 0.017%, respectively; Table 3).
We confirmed by in vitro reverse splicing assays that the RT-
deficient linear and lariat RNPs used in these experiments had
double-strand DNA cleavage activity comparable to that of the
wild-type RNPs (not shown; Fig. 4A shows the same for different
RNP preparations). A possible explanation is that lariat or linear
intron RNA attached to the 59 end of the 39 exon inhibits
recombination by impeding strand resection, but cannot be
removed efficiently in X. laevis oocyte nuclei unless cDNA occurs to
make the RNA a substrate for an endogenous RNase H. Together,
the above experiments indicate that RNPs reconstituted with lariat
or linear intron RNA and RT-proficient LtrA protein are the
preferred means of introducing the recombinogenic double-strand
break in X. laevis oocyte nuclei.
Effect of chromatinization on group II intron targeting
reactions
Plasmid DNAs injected into Xenopus oocyte nuclei become
chromatinized over 4 h [50]. As shown in Table 4, when we
injected target plasmid DNA and incubated the oocytes for 4 h at
room temperature to allow chromatinization prior to injecting
Ll.LtrB RNPs, both the group II intron-integration and double-
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were inhibited strongly (the site-specific integration efficiency
decreased from 22 to 0.55% in Exp. 1 and from 8.9 to 0.28% in
Exp. 2; and the double-strand break-stimulated homologous
recombination efficiency decreased from 2.1% to 0.04% in Exp.
3). In all cases, the persistence of target plasmid DNA in the oocyte
nuclei was verified by the recovery of large numbers of Amp
R
colonies in the chromatinized samples (Table 4). The residual site-
specific intron integration and recombination reactions after
chromatinization could reflect activity of the RNPs on chroma-
Figure 4. Target DNA cleavage and target DNA-primed reverse transcription reactions of RNPs reconstituted with lariat or linear
Ll.LtrB intron RNA. Ll.LtrB RNPs containing lariat or linear intron RNA were incubated with
32P-labeled DNA oligonucleotide substrates containing
the Ll.LtrB target site (positions 256 to +73 from the Ll.LtrB intron-insertion site), and the products were analyzed in a denaturing polyacrylamide gel.
(A) Lariat and linear RNPs were incubated with internally labeled DNA substrate for 30 min at 37uC, as described in Materials and Methods. (B) and (C)
Lariat and linear RNPs incubated with DNA substrates labeled (asterisk) at the 59-end of the top and bottom strand, respectively in the presence of
0.2 mM dATP, dCTP, dGTP, and dTTP for 30 min at 37uC. In (A)–(C), products are indicated to the right of the gel. The schematic at the bottom
diagrams the products expected for each reaction. All lanes are from the same gel, but some lanes in (A) were rearranged to appear adjacent.
doi:10.1371/journal.pone.0003121.g004
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had not been chromatinized. The histone deacetylase inhibitor
trichostatin A (TSA) added to the oocyte incubation medium
before injection of the target plasmid resulted in at most a small
increase in the intron-integration or homologous recombination
efficiencies (Table 4). In other experiments, similar results were
obtained with 50 mM sodium butyrate, another histone deacety-
lase inhibitor (not shown). These findings indicate that chromatin
poses a significant barrier to group II intron gene targeting
reactions, presumably because it impedes access of group II intron
RNPs to their DNA target sites.
Mg
2+-dependent group II intron integration into plasmid
target sites in Drosophila melanogaster and zebrafish
embryos
The effects of chromatinization are expected to be mitigated
during DNA replication, as occurs in developing embryos. To test
whether the group II intron-integration reaction could occur in D.
melanogaster and zebrafish embryos, we carried out RNP microin-
jection experiments using the same plasmid-based intron-integra-
tion assay used in X. laevis oocyte nuclei (see Fig. 1). For Drosophila,
the target plasmid DNA with or without extra Mg
2+ and group II
intron RNPs were injected sequentially into the posterior of
precellular blastoderm stage embryos, and for zebrafish, they were
injected sequentially into the cytoplasm of one-cell embryos.
As shown in Table 5, we observed reasonably efficient Mg
2+-
dependent group II intron integration into the plasmid target site
in both D. melanogaster and zebrafish embryos, as measured by the
recovery of Tet
R+Amp
R plasmids in E. coli. In both organisms,
precise group II intron integration at the target site was confirmed
by PCR and sequencing both the 59- and 39-integration junctions
(not shown), and we observed little or no group II intron
integration if extra MgCl2 was not injected with the target
plasmid. For D. melanogaster, where the injection volumes were
,0.3 nl, we obtained the highest integration efficiencies by
injecting 250 mM MgCl2 with the target plasmid. Assuming an
embryo volume of 7.3 nl [55], the calculated increase in
intracellular Mg
2+ resulting from this injection would be
,10 mM. For zebrafish, where the injection volumes were ,10
nl, the highest integration efficiencies were obtained by injecting
150 mM MgCl2, which assuming an embryo volume of 200 nl
[56], corresponds to a calculated increase of intracellular Mg
2+ of
7.5 mM or higher if one corrects for the 77% of embryo volume
made up by the less permeable yolk. Thus, in both Drosophila and
zebrafish embryos, the calculated increase in intracellular Mg
2+
concentrations required to give maximal Ll.LtrB intron integra-
tion are in the same range as that found for X. laevis oocytes
(,9 mM). These findings suggest that a similar requirement for
additional Mg
2+ for maximal group II intron RNP integration
may be a common feature of eukaryotic organisms.
For zebrafish embryos, hatch rates after the double injection of
500 mM MgCl2 and RNPs were 27–52% compared to 35% for a
single injection of distilled water. For D. melanogaster embryos, the
hatch rate after a single injection of 100 mM MgCl2,a
concentration that supports chromosomal gene targeting (see
below), was 69%. However, a double injection of 100 mM MgCl2
and RNP buffer decreased the hatch rate to 31% (not shown).
Thus, both D. melanogaster and zebrafish appear reasonably tolerant
of the high Mg
2+ concentrations required to support group II
intron integration, but the double injection appears better
Table 3. Group II intron-stimulated homologous
recombination in X. laevis oocyte nuclei with RNPs containing
lariat or linear intron RNA and wild-type or RT-deficient intron-
encoded protein.
Condition Amp
R+Tet
R Amp
R Targeting (%)
Lariat RNP 2.0610
2 2.2610
4 0.9
Linear RNP 91 3.4610
4 0.26
Lariat RNP-RT
2 15 4.2610
4 0.03
Linear RNP-RT
2 7.3 4.3610
4 0.017
Target plasmid pBRR3-ltrB (4.1 ng) and linear donor DNA (17 ng) were injected
together into X. laevis oocyte nuclei in 16 nl of a solution containing 500 mM
MgCl2, followed within 1 min by injection of Ll.LtrB RNPs (38 ng, 20 nl). RNPs
were reconstituted with Ll.LtrB lariat or linear intron RNA without a T7 promoter
in DIV and wild-type or RT-deficient mutant LtrA protein (RT
2). After incubating
for 2 h at 25uC, nucleic acids were extracted from 10 pooled oocytes for each
condition and electroporated into E. coli HMS174(DE3). Targeting efficiencies
were determined by the ratio of (Tet
R+Amp
R)/Amp
R colonies, as in intron-
integration assays (Fig. 1 and Materials and Methods). The experiment was
repeated three times with similar results.
doi:10.1371/journal.pone.0003121.t003
Table 4. Effect of chromatinization of the target plasmid on
group II intron site-specific DNA integration and group II
intron-stimulated homologous recombination in X. laevis
oocyte nuclei.
Condition Amp
R+Tet
R Amp
R
Targeting
(%)
Exp. 1
TP+RNP 4.8610
2 2.2610
3 22
cTP+RNP 242 4.4610
4 0.55
cTP+RNP+TSA/16 mM 139 2.6610
4 0.53
cTP+RNP+TSA/64 mM 166 1.7610
4 0.98
Exp. 2
TP+RNP 2.5610
3 2.8610
4 8.9
cTP+RNP 97 3.4610
4 0.28
cTP+RNP+TSA/64 mM 121 2.3610
4 0.53
cTP+RNP+TSA/320 mM 101 2.0610
4 0.5
Exp. 3
TP+RNP+Donor DNA 45 2.1610
3 2.1
cTP+RNP+Donor DNA 8.7 2.2610
4 0.04
cTP+RNP+Donor DNA+TSA/16 mM 6 2.4610
4 0.02
cTP+RNP+Donor DNA+TSA/64 mM 8 1.1610
4 0.07
Target plasmid (TP) pBRR3-ltrB (4.1 ng, 16 nl) was injected into X. laevis oocyte
nuclei. In one trial (top row in each experiment), the injection of target plasmid
was followed within 1 min by the separate injection of 500 mM MgCl2/17 mM
dNTPs and Ll.LtrB RNPs, while in other trials, the oocytes were incubated for 4 h
at room temperature to allow chromatinization of the target plasmid (cTP) prior
to injection of MgCl2/17 mM dNTPs and RNPs. RNPs in experiments 1 and 2
were reconstituted with Ll.LtrB lariat RNA containing a T7 promoter in DIV,
while in experiment 3, RNPs were reconstituted with Ll.LtrB lariat RNA without a
T7 promoter. When used, trichostatin A (TSA) was added to the medium at the
indicated concentration just prior to injection of the target plasmid. Ten
oocytes were injected for each condition. After overnight incubation at 25uC,
nucleic acids were extracted, electroporated into E. coli HMS174(DE3), and
assayed for targeting by determining the ratio of (Tet
R+Amp
R)/Amp
R colonies,
as described in Figure 1 and Materials and Methods. Experiments 1 and 2 are
independent repeats with different batches of oocytes, while Experiment 3 was
done with the same batch of oocytes as Experiment 1. A repeat of group II
intron-stimulated homologous recombination with a different batch of oocytes
gave similar results for unchromatinized and chromatinized target plasmid
(targeting efficiencies 1.15 and 0.06%, respectively).
doi:10.1371/journal.pone.0003121.t004
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We did not notice any further decrease in embryo viability caused
by the injection of RNPs beyond that caused by the injections of
Mg
2+ and RNP buffer. We note, however, that toxicity could be
greater at higher RNP concentrations or with RNPs targeted to
different sites and will need to be assessed carefully in each case.
Site-specific integration into chromosomal DNA target
sites in D. melanogaster embryos
Finally, we used the D. melanogaster embryos to test whether the
reaction conditions we developed in plasmid targeting assays could
also be used for site-specific integration into chromosomal target
sites. For this purpose, we used retargeted Ll.LtrB introns
(‘‘targetrons’’) designed to insert at two different sites in the yellow
(y) gene (Fig. 5A). These targetrons are denoted Y18a and Y3776s,
where the number corresponds to the nucleotide residue 59 to their
insertion site in the target gene numbered from the ‘‘A’’ of the
ATG initiation codon, and ‘‘a’’ or ‘‘s’’ indicate antisense and sense
strand, respectively.
In the first experiment (Fig. 5B), D. melanogaster embryos at the
precellular blastoderm stage were injected with 100 mM Mg
2+ plus
17 mM dNTPs, followed by Y18a lariat RNPs. After incubation for
1ha t3 0 uCf o l l o w e db y4 8ha t1 8 uC, nucleic acids were extracted
from 50 pooled embryos and analyzed by PCR. The PCRs showed
bandscorresponding to the expected59-a n d3 9-integration junctions
(Fig. 5B), and precise integration at the correct site in the y gene was
confirmed by sequencing the PCR products (not shown). A similar
double-injection experiment showed precise integration of Y3776s
lariat RNPs at their target site, detected by PCR and confirmed by
sequencing of the 39-integration junction in 40 pooled embryos. For
both targetrons, integration into the chromosomal target sites was
not detected without injection of Mg
2+.
The decreased viability caused by double injection (see above)
made it desirable to develop single-injection conditions. As
indicated previously, however, group II intron RNPs tend to
aggregate when injected with the relatively high concentrations of
Mg
2+ required for efficient DNA integration. Thus, we tested
whether substitution of polyamines might enable us to lower the
amount of Mg
2+ that must be injected with the RNPs. Polyamines
had been shown previously to reduce the Mg
2+ requirement for
group II intron self-splicing reactions [57]. Figure 5D shows that a
single injection of linear Y3776s RNPs with 5 mM Mg
2+ and a
polyamine cocktail containing 5 mM putrescine, 3 mM spermi-
dine, 1 mM spermine, corresponding to polyamine ratios in D.
melanogaster larvae [58], gave site-specific integration into the y
gene, detected by PCR in 30 pooled embryos and confirmed by
sequencing the 39-integration junction. Viability as measured by
hatch rate after injection of this polaymine/Mg
2+ mixture was
similar to that for a single injection of distilled water. Thus, the use
of polyamines to reduce the Mg
2+ requirement for group II intron
function provides a potential solution to the problem of double
injection into D. melanogaster embryos, enabling the introduction of
RNPs and required supplements in a single injection that gives
chromosomal gene targeting.
Discussion
Here, by using group II intron RNP microinjection assays, we
show that group II intron-based gene targeting reactions can occur
efficiently in eukaryotes, but are dependent upon the injection of
additional Mg
2+. First, we demonstrated Mg
2+-dependent group II
intron integration promoted by RNPs into plasmid target sites in
X. laevis oocyte nuclei and used the facile X. laevis system to
optimize reaction conditions. Then, by using these conditions, we
showed similar Mg
2+-dependent group II intron integration into
plasmid target sites in both Drosophila and zebrafish embryos, and
in Drosophila, we extended the methods to demonstrate site-specific
integration into chromosomal target sites. We also show that with
the injection of additional Mg
2+, group II intron RNPs injected
into X. laevis oocyte nuclei can be used to introduce a targeted
double-strand break that stimulates gene targeting by homologous
recombination. Thus, our results demonstrate that group II
introns can potentially be used for two types of gene targeting
reactions, site-specific integration and double-strand break-stimu-
lated homologous recombination, in higher organisms.
The finding that Ll.LtrB intron RNP activity is limited by Mg
2+
concentration in eukaryotes differs from the situation in bacteria,
the natural hosts of group II introns, where free Mg
2+
concentrations are apparently sufficient to support efficient
mobility of Ll.LtrB and other group II introns. Group II introns
seem to be particularly sensitive to low Mg
2+ concentrations.
Studies of yeast mtDNA group II introns showed that mutations in
Mg
2+ transporters that result in decreased intramitochondrial
Mg
2+ concentrations strongly inhibit the splicing of all four group
II introns, which belong to different structural subclasses, while
having relatively little effect on the splicing of group I introns
[44,45]. The group II introns affected by low Mg
2+ concentrations
in yeast mitochondria use different protein co-factors to promote
RNA splicing [45], suggesting that the high Mg
2+ requirement for
group II intron function is a property of the intron RNA. For
eukaryotic model organisms, the limitation of group II intron
function by low Mg
2+ concentrations can be overcome by injecting
additional Mg
2+ or Mg
2+ in combination with polyamines. Longer
term but more general solutions would be to select variants of the
Ll.LtrB intron or to identify other group II introns that can
function efficiently at lower Mg
2+ concentrations.
Although group II intron RNPs can by themselves initiate site-
specific DNA integration and double-strand break-stimulated
Table 5. Plasmid assays for site-specific group II intron
integration in D. melanogaster and zebrafish embryos.
Condition Amp
R+Tet
R Amp
R Integration (%)
D. melanogaster
RNP 0 2.1610
5 0
RNP+TP+0.5 M MgCl2 8.4610
3 3.2610
5 2.7
RNP+TP+0.25 MgCl2 4.0610
4 4.2610
5 9.5
Zebrafish
RNP 6 2.2610
4 0.027
RNP+TP+0.125 M MgCl2 1.1610
2 4.4610
3 2.5
Site-specific integration of group II intron RNPs into a plasmid target site in D.
melanogaster and zebrafish embryos was assayed as described in Figure 1 and
Materials and Methods. In the D. melanogaster experiment, target plasmid (TP)
with or without MgCl2 and Ll.LtrB lariat RNPs were injected separately into the
posterior of 100 precellular blastoderm stage embryos, which were then
incubated for 1 h at 30uC. In the zebrafish experiment, target plasmid with or
without MgCl2 and Ll.LtrB lariat RNPs were injected separately into the
cytoplasm of 10 one-cell embryos and incubated for 1 h at 30uC. After
incubation, nucleic acids were isolated and electroporated into E. coli
HMS174(DE3), and the integration efficiency was determined as the ratio of
(Tet
R+Amp
R)/Amp
R colonies. Qualitatively similar results were obtained in two
independent repeats of the Drosophila experiment with different batches of
RNPs (integration efficiencies 1.2 and 1.8% with 0.25 M or 0.5 M MgCl2 and zero
without MgCl2) and in three independent repeats of the zebrafish experiment
(integration efficiencies 0.56, 0.63, and 0.82% with 0.125 M MgCl2 and 0 to
0.004% without MgCl2).
doi:10.1371/journal.pone.0003121.t005
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processes (see Introduction). An important finding here is that X.
laevis oocyte nuclei appear to have the enzymatic machinery
necessary to complete these reactions. Group II intron-stimulated
homologous recombination is presumably completed by a single-
strand annealing pathway, which has been shown previously to be
active in X. laevis oocyte nuclei [51]. This pathway requires strand-
resection by a 59R39 DNA endonuclease, strand annealing, and
repair of gaps and nicks by DNA polymerase and DNA ligase
activities. The only additional step required specifically for the group
II intron-promoted reaction is the removal of the attached intron
RNA from the 59 end of the 39 exon, which our findings for RT-
deficient RNPs suggest may involve cDNA synthesis to make the
RNAa substrateforendogenousRNaseH[59] (Table 3).Inthecase
of the site-specific DNA integration reaction, the late steps that
require host enzymes likely include degradation of the intron RNA
template strand by the endogenous RNase H, followed by second-
strand DNA synthesis and DNA ligation, which again require DNA
polymerase and DNA ligase activities. Previous studies of group II
intron retrohoming showed that cDNA integration could occur by
different DNA recombination or repair mechanisms in different
organisms [16,17,60]. Collectively, these findings suggest that the
availability of host enzymes to complete group II intron gene
targeting reactions will not be a limitation in most systems.
The ability of group II introns to introduce a targeted double-
strand break that stimulates gene targeting by homologous
recombination was first demonstrated in bacteria [8]. However,
prior studies in yeast mitochondria had shown that this mechanism
is used naturally for the homing of mobile group II introns whose
IEPs lack RT activity [61] and for the repair of abortive group II
intron-integration events [62]. In the present work, we used a
plasmid assay to characterize the group II intron-stimulated
Figure 5. Site-specific integration of retargeted Ll.LtrB introns into chromosomal target sites in the Drosophila melanogaster yellow
(y) gene. (A) DNA target site sequences and Ll.LtrB intron RNA base-pairing interactions for targetrons Y18a and Y3776s. Retargeted Ll.LtrB-DORF
introns (targetrons) are denoted by a number that corresponds to the nucleotide position 59 to the Ll.LtrB intron-insertion site numbered from the A
of the ATG initiation codon, followed by ‘‘a’’ or ‘‘s’’, indicating sense and antisense strand respectively. The DNA target sequences are shown from
positions 230 to +15 from the intron-insertion site, with nucleotide residues that match those in the wild-type Ll.ltrB intron target sequence [7]
highlighted in gray in the top strand. The intron-insertion site (IS) in the top strand and the IEP-cleavage site (CS) in the bottom strand are indicated
by arrowheads. Below is shown a schematic of the Drosophila yellow (y) gene (NCBI accession number P09957), with the targetron-insertion sites
indicated, and a diagram of the PCRs used to detect site-specific targetron insertion. y gene exons are gray rectangles, and introns and flanking
sequences are lines. PCR primers used to detect and sequence the targetron integrations are indicated by numbered arrows. (B) PCR analysis of
targetron Y18a integration using a double-injection protocol. Fifty embryos were injected with a solution containing 100 mM MgCl2+17 mM dNTPs
followed by Y18a lariat RNPs (0.9 mg/ml). The embryos were incubated for 1 h at 30uC followed by 48 h at 18uC. Nucleic acids were isolated, and PCR
products corresponding to the 59- and 39-junctions of Y18a integrated at its chromosomal target site (1,156-bp and 238-bp, respectively) were
detected by nested PCR using the following primer pairs: 59-junction, primers 1 (LtrB+940a) and 2 (yellow+277a), followed by primers 3 (LtrB+933a)
and 4 (yellow+241a); 39-junction, primers 5 (LtrB+788s) and 6 (yellow-350a), followed by primers 7 (LtrB+880s) and 8 (yellow-160s) (see Materials and
Methods). (C) PCR analysis of targetron Y3776s integration using a double-injection protocol. Forty embryos were injected with 100 mM MgCl2
followed by Y3776s lariat RNPs (1.3 mg/ml), and the embryos were then incubated for 30 min at 37uC. Nucleic acids were isolated, and a 702-bp PCR
product corresponding to the 39-junction of Y3776s integrated at its target site was detected by PCR using primers 5 (LtrB+788s) and 9
(yellow+4325a) (see Materials and Methods). The dark band at the bottom of the gel is RNA. (D) PCR analysis of Y3776s integration using a single-
injection protocol. Thirty embryos were injected with a solution containing100 mM KCl, 5 mM putrescine dihydrochloride, 3 mM spermidine
trihydrochloride, 1 mM spermine tetrahydrochoride, 5 mM MgCl2, and Y3776s linear RNPs (0.5 mg/ml). After incubating the embryos for 30 min at
37uC, nucleic acids were isolated as described above, and a 348-bp PCR product (arrow) corresponding to the 39-junction for Y3776s integrated at its
target site was detected by nested PCR using primers 5 (LtrB+788s) and 9 (yellow+4325a), followed by primers 10 (LtrB+870s) and 11 (yellow+4054a)
(see Materials and Methods). Other bands in the gel are likely due to non-specific annealing of the primers. In (B–D), the PCR products were analyzed
by electrophoresis in a 1% agarose gel, which was stained with ethidium bromide, and the identities of the PCR products were confirmed by
sequencing across the integration junctions (not shown).
doi:10.1371/journal.pone.0003121.g005
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group II intron RNPs reconstituted with linear as well as lariat
intron RNA can be used to introduce the targeted double-strand
break. This is so because although linear intron RNA is incapable
of complete reverse splicing, it is fully competent to carry out the
first step, attachment of the intron RNA to the 59 end of the 39
exon, leaving a DNA strand break. For both linear and lariat
intron RNA, DNA cleavage occurs by a transesterification
reaction with the attachment of the intron RNA to the target
DNA and not by hydrolysis, a mechanism used for group II intron
ribozyme cleavage of RNA substrates [63,64]. The use of linear
intron RNA facilitates the preparation of RNPs needed for gene
targeting because it can be obtained directly by in vitro
transcription without the self-splicing step needed for the
preparation of lariat RNA.
In addition to their practical applications, our findings for RNPs
containing linear intron RNA also have implications for group II
intron mobility mechanisms. Some group II introns splice in vivo by
using hydrolysis rather than branch-point formation for cleavage
at the 59 splice site, leading to the production of linear intron RNA
[65–67]. Our findings suggest that such group II introns could be
mobile by a mechanism involving partial reverse splicing into the
target DNA, leading to attachment of linear intron RNA to the 59
end of the 39 exon, followed by second-strand cleavage and target
DNA-primed reverse transcription of the linear intron RNA,
provided that cellular enzymes could complete ligation of the
cDNA into the target site.
Unsurprisingly, our results show that chromatinization of the
plasmid DNA target site in X. laevis oocyte nuclei strongly inhibits
both group II intron DNA integration and double-strand break-
stimulated homologous recombination, presumably because it
impedes access of the RNPs to the DNA target site. Although the
inhibition by chromatinization appears greater for group II intron
RNPs than was observed previously for the meganuclease I-SceI in
analogous experiments in X. laevis oocyte nuclei [50], the two
datasets are not strictly comparable without information about the
degree of chromatinization of the different target sites. As for other
gene targeting methods, interference from chromatin with group
II intron gene targeting is expected to be mitigated in systems
undergoing active transcription or DNA replication. Accordingly,
we show here that microinjected group II intron RNPs promote
efficient Mg
2+-dependent plasmid targeting in both Drosophila and
zebrafish embryos, and in the Drosophila, we show that optimal
conditions developed in plasmid targeting assays can be used for
site-specific integration into two different chromosomal target sites
in the y gene. In both cases, the site-specific integration into
chromosomal DNA occurred at frequencies high enough to detect
by PCR and confirm by sequencing in 50 or less pooled embryos.
Unlike previously developed Drosophila gene targeting methods
[40,68], the group II intron-integration method has the advantage
of requiring only microinjection of RNPs and is not dependent
upon prior strain construction and crosses to generate flies
expressing DNA endonucleases and linear donor DNA.
Both group II intron integration and double-strand break-
stimulated homologous recombination are potentially powerful
methods for gene targeting in higher organisms. As retroelements
akin to retroviruses, group II introns have a highly evolved DNA
integration mechanism, which enables targeted rather than
random integration. Further, we showed previously that mobile
group II introns could be used as vectors to integrate genetic
markers or cargo genes cloned in domain IV at desired DNA
target sites in bacteria [5,9,43]. For applications in gene therapy, a
potential advantage of the group II intron-integration reaction is
that it can be accomplished by introduction of assembled RNPs
without adding exogenous DNA that could result in deleterious
ectopic integrations. For double-strand break-stimulated homolo-
gous recombination, the potential advantages of group II introns
are that they have inherently very high target specificity and that
the double-strand break can be targeted to different locations
simply by modifying the base-pairing sequences in the intron
RNA, without the need for protein engineering to change target
specificity as for protein endonucleases. While further work will be
required to develop the group II intron-based methods for routine
use, our findings indicate that under appropriate conditions
microinjected group II intron RNPs are highly active in
eukaryotes, can access plasmid or chromosomal target sites, and
can integrate or introduce double-strand breaks into those target
sites at reasonably high efficiency. Thus, there appear to be no
insurmountable barriers to using group II introns for gene
targeting in eukaryotes.
Materials and Methods
Recombinant plasmids
pACD2 and pACD3 are intron-donor plasmids used for in vitro
transcription of wild-type Ll.LtrB-DORF intron RNA, which is
then reconstituted with purified LtrA protein to form RNPs
(‘‘targetrons’’) for gene targeting [4,8]. Both plasmids contain the
0.9-kb Ll.LtrB-DORF intron and flanking exons cloned down-
stream of a T7lac promoter in a pACYC184-based vector with a
cam
R gene, and have the LtrA ORF cloned downstream of the 39
exon. In pACD2, the Ll.LtrB-DORF intron contains an additional
phage T7 promoter inserted in intron domain IV (DIV) for use in
plasmid-based DNA-integration assays. pACD4C and pACD4G
are derivatives of pACD3, which have C or G at the d9 +1 position
in the 39 exon and were used for construction and in vitro
transcription of targetrons Y18a and Y3776s, respectively [7]. The
latter are Ll.LtrB-DORF introns in which the EBS2, EBS1 and d
sequences were modified to be complementary to IBS2, IBS1, and
d9 sequences in DNA target sites in the D. melanogaster yellow (y)
gene. The donor plasmid used for each targetron has a d9 residue
in the 39 exon complementary to the retargeted d residue in the
intron RNA for optimal RNA splicing [7].
pBRR3-ltrB, the target plasmid for intron-integration assays,
contains the Ll.LtrB homing site (ligated exon 1 and 2 of the ltrB
gene from position 2178 upstream to +91 downstream of the
intron-insertion site) cloned upstream of a promoterless tet
R gene in
an Amp
R pBR322-based vector [4,8].
pIMP-1P, used for expression of the LtrA protein, contains the
LtrA ORF cloned downstream of a tac promoter and W10 Shine-
Dalgarno sequence in the protein-expression vector pCYB2 (New
England Biolabs, Ipswich, MA) [46]. LtrA is expressed from this
plasmid as a fusion protein with a C-terminal tag containing an
intein-linked chitin-binding domain, enabling LtrA purification via
a chitin-affinity column, followed by intein-cleavage. pImp-10P-
DD
2 expresses RT-deficient LtrA (RT
2) with the mutation
YADDRYAAA at the RT active site [69].
pUC19-PUF, used to generate the linear donor DNA for group
II intron-stimulated homologous recombination, contains homol-
ogy arms of 705- and 718-bp upstream and downstream of the
Ll.LtrB-insertion site, respectively, flanking a 3,967-bp phage l
DNA NcoI fragment and a T7 promoter sequence. To construct
this plasmid, the left and right homology arms were amplified from
pBRR3-ltrB with primers pBRR-700BamS (59-CGGCGGATCC-
TTCTTCGGGGCGAAAACTCTCAAGG)+PUFNcoIT7A (59-
GAATTAAAAATGATATGCCCTATAGTGAGTCGTATTAC-
CATGGGTTATGGATGTGTTCAC) and PUFNcoIT7S (59-
GTGAACACATCCATAACCCATGGTAATACGACTCACTA-
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CGGCGGATCCCTGGGCGGCGGCCAAAGCGGTCGGA),
respectively. The PUFNcoIT7A primer introduces a NcoI site
(italics) and a phage T7 promoter (underlined), and the outside
primers introduce BamHI sites (italics). The product obtained in a
second PCR with the outside primers was cloned into the BamHI
site of pUC19, and the 3,967-bp NcoI fragment of phage l DNA
was inserted into the NcoI site.
Preparation and biochemical analysis of group II intron
RNPs
Ll.LtrB-DORF intron RNPs were reconstituted from in vitro-
synthesized intron RNA and purified LtrA protein by a
modification of a method described previously [46]. A precursor
RNA containing the Ll.LtrB-DORF intron and flanking exons was
transcribed with phage T7 RNA polymerase (Megascript T7 Kit;
Ambion, Austin, TX) from the appropriate pACD-based donor
plasmid (see above) which had been linearized with NheI, or with
phage T3 RNA polymerase (Megascript T3 Kit; Ambion) from a
PCR product generated from the donor plasmid, using the 59
primer pACD-T3 (59 GGAGTCTAGAAATTAACCCTCAC-
TAAAGGGAATTGTGAGCG), which appends a T3 promoter
sequence (underlined), and the 39 primer LtrB+744a (59 CTCCT-
CTAGAATCCGCTGTATCATCTAATATTCCTTTTG) or
NheIR (CTAGCAGCACGCCATAGTGACTGGCG). The
resulting precursor RNAs containing the Ll.LtrB-DORF intron
and flanking exon sequences were self-spliced in 1.25 M NH4Cl,
50 mM MgCl2, 50 mM Tris-HCl, pH 7.5 for 3 h at 37uC, then
ethanol-precipitated and dissolved in distilled water.
To reconstitute Ll.LtrB-DORF RNPs, the self-spliced RNA (100
nM) was re-natured by heating to 50 or 55uC in 10 ml of 450 mM
NaCl, 5 mM MgCl2, 40 mM Tris-HCl, pH 7.5 and slowly cooling
to 30uC prior to addition of 200 nM of purified LtrA protein [46]
and further incubation for 30 min at 30uC. The resulting RNPs
were pelleted by ultracentrifugation in a Beckman 50.2 Ti rotor at
145,0006g for 16 h at 4uC and resuspended in 50 mlo f1 0m M
KCl, 10 mM MgCl2, and 40 mM HEPES, pH 8.0. The RNP
preparations typically contain 60–70% intron lariat RNA with the
remainder being precursor RNA plus smaller amounts of linear
intron and ligated exons, and they typically have a concentration
of 2–3 mg RNA/ml based on O.D.260, with the highest obtained
being 5.6 mg/ml.
To make RNPs containing linear intron RNA, Ll.LtrB-DORF
intron RNA was transcribed with phage T3 RNA polymerase
from a PCR product generated from pACD3 using the 59 primer
T3-LIs (AATTAACCCTCACTAAAGGG TGCGCCCAGA-
TAGGGTGTTAAGTCAAG), which appends a T3 promoter
(underlined), and the 39 primer LtrB+940a (GTGAAGTAGG-
GAGGTACCGCCTTGTTC), which corresponds to the 39 end
of the intron. The linear RNA was renatured and reconstituted
with purified LtrA protein [46] as described above for lariat RNPs.
DNA endonuclease assays were carried out with a 129-bp DNA
substrate, which was internally labeled by PCR in the presence of
[a-
32P]dTTP (3,000 Ci/mmol; Perkin-Elmer, Waltham, MA)
[53], or with 60-bp DNA oligonucleotide substrates labeled at the
59 end of the top or bottom strand with [c-
32P]ATP and phage T4
polynucleotide kinase (New England Biolabs). The 60-bp DNA
substrates were prepared by annealing complementary synthetic
oligonucleotides and purified using a centri-sep spin column
(Princeton Separations, Adelphia, NJ). For assays with the
internally labeled DNA substrate, the DNA (1.5 nM; 56,000
cpm) was incubated with RNPs (815 nM) for 30 min at 37uCi n2 0
ml of reaction medium containing 10 mM KCl, 10 mM MgCl2,
and 50 mM Tris-HCl, pH 7.5. For assays with the 59-labeled
DNA substrates, the DNA (50 nM) was incubated with RNPs (100
nM) for 30 min at 37uCi n2 0ml of the same reaction medium plus
0.2 mM each of dATP, dCTP, dGTP, and dTTP (referred to as
dNTPs). After the incubations, the reactions were terminated by
extraction with phenol-chloroform-isoamyl alcohol (25:24:1;
phenol-CIA) followed by ethanol precipitation, and the products
were analyzed by electrophoresis in denaturing 6% or 10% (w/v)
polyacrylamide gels, which were dried and scanned with a
phosphorimager.
X. laevis methods
Mature adult female frogs were obtained from Nasco (Fort
Atkinson, WI). Stage VI oocytes were manually peeled from the
follicle cell layer in isolation medium (108 mM NaCl, 2 mM KCl,
1 mM EDTA, 1 mM HEPES, pH 7.5), treated with 0.05%
collagenase (Sigma-Aldrich, St. Louis, MO) for 10 min, and rinsed
in incubation medium [Barth’s solution (88 mM NaCl, 1 mM
KCl, 0.82 mM MgSO4, 2.4 mM NaHCO3, 0.33 mM Ca(NO3)2,
0.91 mM CaCl2, 10 mM N-2-hydroxyethylpiperazine-N9-ethane-
sulphonic acid, pH 7.4) supplemented with penicillin (10,000
units/l), streptomycin (10 mg/l), gentamycin (50 mg/l), and
theophylline (90 mg/l)]. Oocytes were kept in incubation medium
at 16uC for at least 30 min before injection.
Oocyte nuclear injection was done in incubation medium using
a pressure system (Picospritzer III; Parker Hannifin, Mentor, OH)
with 20 psi output. The injection volume was calibrated to 10–20
nl for each needle. A micromanipulator (MN-151; Narishige,
Tokyo, Japan) was used to manipulate the injection needles.
For plasmid targeting assays, the target plasmid DNA (4–
10 mg/ml) with specified amounts of MgCl2 was injected into
Xenopus laevis oocyte nuclei, followed within 1 min by the injection
of RNPs (0.9–5.6 mg/ml), using different needles to avoid prior
mixing. In most experiments, 17 mM each of dATP, dCTP,
dGTP, and dTTP (dNTPs; Invitrogen, Carlsbad, CA; stocks
concentrated to 70 mM using a Speed-Vac) was injected with the
target plasmid. Integration efficiency increased with increasing
RNP concentrations, but varied between different RNP prepara-
tions. For each experimental condition, 10 to 20 oocytes were
injected and pooled for analysis. After injection, the oocytes were
rinsed twice in incubation medium, incubated for times and
temperatures specified for individual experiments, and stored at
280uC. For time-course experiments, the oocytes were quickly
frozen in dry ice at the specified time after the last injection.
To isolate nucleic acids, the oocytes were thawed and incubated
in lysis buffer [20 mM Tris-HCl, pH 8.0, 5 mM EDTA, 400 mM
NaCl, 1% SDS (w/v), 400 mg/ml proteinase K (Molecular Biology
Grade; Sigma-Aldrich)] for 1 h at 55uC, and then extracted twice
with phenol-CIA. Nucleic acids were precipitated with isopropa-
nol and dissolved in 20–50 ml of distilled water. Two ml of the
nucleic acid preparation was electroporated into E. coli
HMS174(DE3) F
2, hsdR, recA, rif
r (Novagen, EMD Chemicals,
Gibbstown, NJ), and cells were plated at different dilutions on
Luria-Bertani (LB) medium containing ampicillin (50 mg/ml) plus
tetracycline (25 mg/ml) or the same concentration of ampicillin
alone. Colonies were counted after overnight incubation at 37uC,
and the integration efficiency was calculated as the ratio of
(Amp
R+Tet
R)/Amp
R colonies. Site-specific intron integration was
confirmed by PCR using primers For-pBRR (59- CTGATCGA-
TAGCTGAAACGC) and Rev2-pBRR (59-AATGGACGA-
TATCCCGCA) to amplify the inserted intron and flanking
sequences, and then using Rseq (59-CCATGCGAGAGTAGG-
GAAC) and Rev2-pBRR (see above) to sequence the 59- and 39-
integration junctions, respectively.
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reactions, X. laevis oocyte nuclei were injected with a mixture of
closed-circular target plasmid pBRR3-ltrB (4–5 ng) and donor DNA
(4–17 ng) in 10–20 nl of 0.5 M MgCl2, 10 mM Tris-HCl, pH 7.5,
unlessspecified otherwise.ThedonorDNAwasa5.4-kb linearDNA
generated by BamHI-digestion of pUC19-PUF (see above), followed
by phenol-CIA extraction and ethanol precipitation. Ll.LtrB RNPs
(0.9–5.6 mg/ml), without an internal T7 promoter, were injected
into the same oocyte nuclei. Ten to twentyoocytes were injected and
pooled for each experimental condition. The injected oocytes were
incubated under conditions specified for individuals experiments,
then nucleic acids were extracted and electroporated into E. coli
HMS174(DE3), followed by plating on LB containing ampicillin
with or without tetracycline, as for the group II intron-integration
assays (see above).
Zebrafish methods
Wild-type D. rerio strains were the AB line [70]. Zebrafish were
reared at 28.5uC under a 14 h/10 h light/dark cycle, with in vitro
fertilization performed, as described [71]. Fertilized eggs were
incubated at room temperature for ,15 min prior to injection.
For group II intron targeting assays, target plasmid (0.5 mg/ml in
a solution containing 3.125 mM of each dNTP and specified
amounts of MgCl2, with 0.25% phenol red) and Ll.LtrB-DORF
RNPs (0.1 mg/ml with 0.25% phenol red, 10 mM KCl, 10 mM
MgCl2, and 40 mM HEPES, pH 8) were injected separately into
10 to 25 one-cell embryos in Steinberg’s medium [72], using a
pressure system (Picospritzer III; Parker Hannifin) with 20 psi
output. The injection volumes were ,10 nl. A micromanipulator
(MN-151, Narishige) was used to manipulate the injection needles.
After injection, the embryos were washed with Steinberg’s
medium, pooled in a single 1.5-ml Eppendorf tube in 500 ml
Steinberg’s medium, and incubated for 1 h at 30uC, prior to
plasmid DNA extraction and transformation of E. coli, as described
above for X. laevis assays.
D. melanogaster methods
The w
1118 strain was grown in standard fly media at 22uC and
embryos were collected on apple juice agar plates with yeast paste
[73] for collection times not exceeding 40 min. The embryos were
then bleach dechorionated, rinsed in egg wash [0.7% (w/v) NaCl,
0.04% (v/v) Triton X-100], adhered to a 25675 mm slide,
desiccated in a dish that contains Drierite and covered in
Halocarbon oil (700 Series; Halocarbon Products, River Edge,
NJ). Microinjection was done using filament needles with a bore
size of ,5 mm attached to an air-filled 50-ml syringe. A
micromanipulator (MO-150; Narishige) was used to manipulate
the injection needles. The injection volumes were ,0.3 nl.
For plasmid-based group II intron-integration assays, target
plasmid DNA (0.5 mg/ml) supplemented with 17 mM dATP,
dCTP, dGTP, and dTTP (Invitrogen) and specified amounts of
MgCl2 was injected into the posterior of the embryo, followed
within 5 min by the injection of RNPs (1.6 mg/ml), using different
needles to avoid prior mixing. For each experimental condition, 50
to 100 embryos were injected, incubated in a humidified chamber
for 1 h at 30uC, taken up with a pipette, pooled, and homogenized
in lysis buffer (see above) using a hand homogenizer. Plasmid
DNAs were then extracted and transformed into E. coli,a s
described above for X. laevis assays.
For chromosome targeting, precellular blastoderm stage
embryos (,40-min collection time) were injected with targetron
Y18a or Y3776s RNPs, which contain Ll.LtrB introns targeted to
insert at sites in the y gene. Mg
2+, dNTPs, and polyamines were
injected prior to or mixed with the RNPs, and after the injections,
the embryos were incubated, as specified for individual experi-
ments in the legend of Figure 5. Thirty to fifty embryos were then
pooled, and nucleic acids were extracted, as described above.
Targetron integrations were detected by PCR of one fifth of the
extracted DNA using the following primers: Y18a, 59-integration
junction: primers LtrB+940a (59-GTGAAGTAGGGAGGTAC-
CGCCTTGTTC) and yellow+277a (59-ACGATCTCCCCAAG-
GGCTTCAT) and nested primers LtrB+933a (59-AGGGAGGT-
ACCGCCTTGTTCACATTAC) and yellow+241a (59-TACCA-
TCACGCCAGCGGGGAA); Y18a, 39-integration, LtrB+788s
(59-CGACTAATACGACTCACTATAGGGTC) and yellow-
350s (59-GCAAAGTTGGCCGATCTATGGGAAC) and nested
primers LtrB+880s, (59-GAAGAGGGTGGTGCAAACCAGT-
CAC) and yellow-160s, (59-CGCCACGGTCCACAGAAGAG);
Y3776s, 39-integration junction: primers LtrB+788s (see above)
and yellow+4325a (59-ATGCCACCACCCAGATTGG) and nest-
ed primers LtrB+870s and yellow +4054a (59-TGAGGTTTCTG-
TGGCAAGACAGGA). In each case, the PCR products were
purified in a 1% agarose gel and sequenced to confirm integration at
the expected target site.
Treatment of animals
Animal care met the principles and guidelines of the Institute for
Laboratory Animal Research ‘‘Guide for Care and Use of
Laboratory Animals’’ and the University of Texas at Austin
Institutional Animal Care and Use Committee.
Supporting Information
Figure S1 Nuclease-sensitivity of group II intron-integration
products extracted from X. laevis oocyte nuclei. Target plasmid
DNA (4.5 ng/18 nl) with 500 mM MgCl2 and 17 mM dNTPs was
injected into X. laevis oocyte nuclei, followed by Ll.LtrB lariat
RNPs (53 ng/18 nl). The oocytes were incubated at 25uC for the
indicated times and then quick frozen on dry ice. Nucleic acids
were extracted, and equal portions were either untreated or
digested in 10 ml reactions with MluI (10 units, 1 h at 37uC),
RNase A (1 ml Sigma-Aldrich GenElute Mammalian Genomic
DNA Miniprep Kit, 5 min at room temperature) or RNase H
(0.05 units, 20 min at 37uC). MluI and RNase H digestions were
done according to the manufacturers’ protocols, and RNase A
digestion was done in 50 mM NaCl, 10 mM Tris-HCl, pH 7.5.
After digestion, the nucleic acids were extracted twice with phenol-
CIA and ethanol precipitated in the presence of glycogen carrier
prior to electroporation into E. coli HMS174(DE3). Integration
efficiencies were determined as the ratio of (Tet
R+Amp
R)/Amp
R
colonies. O/N, overnight.
Found at: doi:10.1371/journal.pone.0003121.s001 (0.12 MB TIF)
Figure S2 Digestion of DNA and RNA oligonucleotide
substrates with restriction enzymes and ribonucleases A and H.
(A) Single-stranded (ss) DNA, DNA/RNA heteroduplex, and
double-stranded (ds) DNA substrates (0.28 nM; 1,200–9,000 cpm)
were incubated with MluI or KpnI (0, 10, 50, or 100 units; New
England Biolabs) in 100-ml of reaction medium for 1 h at 37uC
according to the manufacturer’s protocol. (B) RNA, RNA/DNA
heteroduplex, and double-stranded DNA substrates (0.28 nM;
1,200–9,000 cpm) were incubated in 100-ml reactions with RNase
A (0, 0.2, 2, and 10 ml; Sigma-Aldrich GenElute Mammalian
Genomic DNA Miniprep Kit) or RNase H (0, 0.5, and 50 units;
New England Biolabs). RNase A digestion was done in 50 mM
NaCl, 10 mM Tris-HCl, pH 7.5 for 5 min at room temperature,
and RNase H digestion was done for 20 min at 37uC according to
the manufacturer’s protocol. In (A) and (B), substrates were DNA
oligonucleotide 59 TGAACAAGGCGGTACCTCCCTTGGC-
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to a complementary DNA or RNA oligonucleotide, or the
complementary RNA strand by itself. DNA and RNA oligonu-
cleotides were obtained from Integrated DNA Technologies
(Coralville, IA) and 59-end labeled with [c-
32P]ATP (10 Ci/mmol;
Perkin-Elmer) using phage T4 polynucleotide kinase (New
England Biolabs) according to the manufacturer’s protocol, then
gel-purified in a denaturing 6% (w/v) polyacrylamide gel. In the
ssDNA, DNA/RNA duplex, and dsDNA substrates, the DNA
oligonucleotide was labeled, whereas in the RNA and RNA/DNA
duplex substrates, the RNA oligonucleotide was labeled. Duplexes
were formed by incubating the labeled oligonucleotide with an
equal amount of unlabeled complementary strand, heating to
95uC and slow cooling to room temperature, then gel purifying in
a 2% agarose gel containing Tris-borate-EDTA buffer (90 mM
Tris, 90 mM boric acid, 2 mM EDTA). After incubation with the
indicated enzymes, samples were extracted with phenol-CIA and
ethanol precipitated in the presence of linear acrylamide carrier
(58 mg/ml). Restriction enzyme digests were analyzed in a
denaturing 8% (w/v) polyacrylamide gel, and RNase A and H
digestions were analyzed in a denaturing 15% (w/v) polyacry-
lamide gel. Size markes were 59-labeled 50- and 18-nt DNA
oligonucleotides. The gels were dried and scanned with a
phosphorimager.
Found at: doi:10.1371/journal.pone.0003121.s002 (3.45 MB TIF)
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